CIBC Asset Management Inc Purchases 654 Shares of STERIS plc (NYSE:STE)

CIBC Asset Management Inc increased its position in STERIS plc (NYSE:STE) by 4.5% during the 4th quarter, HoldingsChannel.com reports. The fund owned 15,045 shares of the medical equipment provider’s stock after buying an additional 654 shares during the period. CIBC Asset Management Inc’s holdings in STERIS were worth $3,093,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently bought and sold shares of STE. Magnolia Capital Advisors LLC boosted its position in STERIS by 1.9% in the fourth quarter. Magnolia Capital Advisors LLC now owns 2,534 shares of the medical equipment provider’s stock valued at $521,000 after buying an additional 48 shares in the last quarter. SkyView Investment Advisors LLC raised its stake in shares of STERIS by 1.6% in the third quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider’s stock worth $765,000 after acquiring an additional 51 shares during the last quarter. Park Edge Advisors LLC raised its stake in shares of STERIS by 1.1% in the fourth quarter. Park Edge Advisors LLC now owns 4,662 shares of the medical equipment provider’s stock worth $958,000 after acquiring an additional 51 shares during the last quarter. Opal Wealth Advisors LLC raised its stake in shares of STERIS by 5.7% in the fourth quarter. Opal Wealth Advisors LLC now owns 1,118 shares of the medical equipment provider’s stock worth $230,000 after acquiring an additional 60 shares during the last quarter. Finally, Sage Private Wealth Group LLC raised its stake in shares of STERIS by 4.1% in the fourth quarter. Sage Private Wealth Group LLC now owns 1,537 shares of the medical equipment provider’s stock worth $316,000 after acquiring an additional 61 shares during the last quarter. Institutional investors own 94.69% of the company’s stock.

Analyst Ratings Changes

STE has been the subject of a number of research analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research note on Friday, November 8th. Stephens reaffirmed an “overweight” rating and issued a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. Piper Sandler boosted their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. StockNews.com downgraded shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 29th. Finally, JMP Securities reaffirmed a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research note on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $258.75.

Insider Buying and Selling at STERIS

In other STERIS news, SVP Cary L. Majors sold 1,682 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $217.32, for a total value of $365,532.24. Following the completion of the sale, the senior vice president now owns 11,372 shares of the company’s stock, valued at approximately $2,471,363.04. This represents a 12.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.14% of the company’s stock.

STERIS Trading Down 0.3 %

STE opened at $220.73 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The company has a market cap of $21.69 billion, a price-to-earnings ratio of 46.86 and a beta of 0.84. The firm has a 50 day simple moving average of $213.47 and a 200 day simple moving average of $223.64. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24.

STERIS (NYSE:STE) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, sell-side analysts anticipate that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be paid a $0.57 dividend. This represents a $2.28 annualized dividend and a yield of 1.03%. The ex-dividend date of this dividend is Thursday, February 20th. STERIS’s payout ratio is presently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.